<PAGE>
----------------------------
UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION ----------------------------
Washington, D.C. 20549 OMB Number: 3235--145
Expires: December 31, 1997
Estimated average burden
hours per response....14.90
----------------------------
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
ILEX Oncology, Inc.
- -------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
- -------------------------------------------------------------------------------
(Title of Class of Securities)
451923106
----------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
<PAGE>
- ------------------- ----------------------
CUSIP No. 451923106 13G Page 2 of 12 Pages
- ------------------- ----------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Boston Capital Ventures III, Limited Partnership
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY -------------------------------------------------
OWNED BY
EACH 6 SHARED VOTING POWER
REPORTING 771,547
PERSON -------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
0
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
771,547
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
771,547
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON *
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------- ----------------------
CUSIP No. 451923106 13G Page 3 of 12 Pages
- ------------------- ----------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BD Partners Limited Partnership
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY -------------------------------------------------
OWNED BY
EACH 6 SHARED VOTING POWER
REPORTING 771,547
PERSON -------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
0
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
771,547
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
771,547
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON *
PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------- ----------------------
CUSIP No. 451923106 13G Page 4 of 12 Pages
- ------------------- ----------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
A. Dana Callow, Jr.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 21,178
BENEFICIALLY -------------------------------------------------
OWNED BY
EACH 6 SHARED VOTING POWER
REPORTING 771,547
PERSON -------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
21,178
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
771,547
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
792,725
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.5%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON *
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------- ----------------------
CUSIP No. 451923106 13G Page 5 of 12 Pages
- ------------------- ----------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
H.J. von der Goltz
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Guatemala
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY -------------------------------------------------
OWNED BY
EACH 6 SHARED VOTING POWER
REPORTING 771,547
PERSON -------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
0
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
771,547
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
771,547
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON *
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------- ----------------------
CUSIP No. 451923106 13G Page 6 of 12 Pages
- ------------------- ----------------------
- -------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
David Kronfeld
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- -------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY -------------------------------------------------
OWNED BY
EACH 6 SHARED VOTING POWER
REPORTING 771,547
PERSON -------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
0
--------------------------------------------------
8 SHARED DISPOSITIVE POWER
771,547
- -------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
771,547
- -------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
- -------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
6.3%
- -------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON *
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- ------------------ -------------------------
CUSIP No. 451923106 13G Page 7 of 12 Pages
- ------------------ -------------------------
NOTE: This Statement on Schedule 13G is being filed on behalf of (i)
Boston Capital Ventures III, Limited Partnership; (ii) BD Partners Limited
Partnership; (iii) A. Dana Callow, Jr.; (iv) H. J. von der Goltz; and (v)
David Kronfeld.
Item 1.
(a) Name of Issuer
------------------
ILEX Oncology, Inc.
(b) Address of Issuer's Principal Executive Offices
-----------------------------------------------
1150 I.H. 10 West
Suite 300
San Antonio, Texas 78230
Item 2.
<TABLE>
<CAPTION>
Item 2(a) Item 2(b) Item 2(c)
---------- ----------- ----------------------
Citizenship or Place
Name of Person Filing Address of Organization
--------------------- --------- -----------------------
<S> <C> <C>
Boston Capital Ventures III, c/o Boston Capital Delaware
Limited Partnership Ventures
("BCV III") 45 School Street
Boston, MA 02108
BD Limited Partnership c/o Boston Capital Delaware
("BDP"), the sole general Ventures
partner of BCV III 45 School Street
Boston, MA 02108
A. Dana Callow, Jr., c/o Boston Millennia United States
a general partner Partners
of BDP 30 Rowes Wharf
Boston, MA 02110
H. J. von der Goltz, c/o Boston Capital Guatemala
a general partner Ventures
of BDP 45 School Street
Boston, MA 02108
David Kronfeld, a JK & B Capital United States
general partner 205 N. Michigan Avenue,
of BDP Suite 808
Chicago, IL 60601
</TABLE>
Item 2(d).
Title of Class of Securities
- -----------------------------------
Common Stock, $.01 par value
Item 2(e).
CUSIP Number
- ---------------
451923106
<PAGE>
- ------------------ -------------------------
CUSIP No. 451923106 13G Page 8 of 12 Pages
- ------------------ -------------------------
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13(d)-2(b),
check whether the person filing is a:
(a) ---- Broker or Dealer registered under Section 15 of the
Securities Exchange act of 1934 ("the Act").
(b) --- Bank as defined in Section 3(a)(6) of the Act.
(c) ---- Insurance Company as defined in Section 3(a)(19) of the Act.
(d) --- Investment Company registered under Section 8 of the
Investment Company Act of 1940.
(e) --- Investment adviser registered under Section 203 of the
Investment Advisers Act of 1940.
(f) --- Employee Benefit Plan, Pension Fund which is subject to the
provision of the Employee Retirement Income Security Act of
1974 or endowment Fund; see Rule 13-d(b)(1)(ii)(F) of the
Act.
(g) --- Parent Holding company, in accordance with Rule
13(d)-1(b)(ii)(G) of the Act.
(h) --- Group, in accordance with rule 13d-1(b)(ii)(H) of the Act.
None of the above.
Item 4. Ownership.
(a) Amount Beneficially Owned
As of December 31, 1997, each of the following is the holder of record of
(i) the number of shares of Common Stock and (ii) warrants for the purchase of
the number of shares of Common Stock, indicated below;
<TABLE>
<CAPTION>
Common Stock Warrants
---------------- --------------
<S> <C> <C>
BCVIII 707,418 shares 64,129
BDP 707,418 shares 64,129
Mr. Callow 14,385 shares 1,081
Mr. von der Goltz 0 shares 0
Mr. Kronfeld 0 shares 0
</TABLE>
In addition, Mr. Callow may be deemed the beneficial owner of 5,712 shares
subject to stock options which are currently exercisable or exercisable
within 60 days from the date hereof..
(b) Percent of Class
<TABLE>
<S> <C>
BCVIII 6.3%
BDP 6.3%
Mr. Callow 6.5%
Mr. von der Goltz 6.3%
Mr. Kronfeld 6.3%
</TABLE>
(c) Number of shares as to which such person has:
(i) sole power to vote or direct the vote:
<TABLE>
<S> <C>
BCVIII 0
BDP 0
Mr. Callow 21,178
Mr. von der Goltz 0
</TABLE>
<PAGE>
- ------------------ -------------------------
CUSIP No. 451923106 13G Page 9 of 12 Pages
- ------------------ -------------------------
<TABLE>
<S> <C>
Mr. Kronfeld 0
</TABLE>
(ii) shared power to vote or direct the vote:
<TABLE>
<S> <C>
BCVIII 771,547
BDP 771,547
Mr. Callow 771,547
Mr. von der Goltz 771,547
Mr. Kronfeld 771,547
</TABLE>
(iii) sole power to dispose or to direct the disposition of:
<TABLE>
<S> <C>
BCVIII 0
BDP 0
Mr. Callow 21,178
Mr. von der Goltz 0
Mr. Kronfeld 0
</TABLE>
(iv) shared power to dispose or to direct the disposition of:
<TABLE>
<S> <C>
BCVIII 771,547
BDP 771,547
Mr. Callow 771,547
Mr. von der Goltz 771,547
Mr. Kronfeld 771,547
</TABLE>
Each of BCVIII, BDP, Mr. Callow, Mr. von der Goltz and Mr. Kronfeld
expressly disclaims beneficial ownership of any shares of Common Stock of
ILEX Oncology, Inc., except any shares held directly of record or any shares
in which they have an actual pecuniary interest.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following: / /
Not applicable.
Item 6. Ownership of More than five Percent on Behalf of another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which
acquired the Security Being Reported on by the Parent Holding
Company.
Not applicable.
Item 8. Identification and Classification of Member of the Group.
Not applicable. BCVIII, BDP, Mr. Callow, Mr. von der Goltz and
Mr. Kronfeld expressly disclaim membership in a "group" as
defined in Rule 13d-1(b)(1)(ii)(H).
Item 9. Notice of Dissolution of Group.
Not applicable.
<PAGE>
- ------------------ -------------------------
CUSIP No. 451923106 13G Page 10 of 12 Pages
- ------------------ -------------------------
Item 10. Certification.
Not applicable. This statement on Schedule 13G is not filed
pursuant to Rule 13d-1(b).
Attached as Exhibit 1 hereto is a Joint Filing Agreement executed by each
of the filing persons pursuant to Rule 13-1(f) under Section 13(d) of the Act.
<PAGE>
- ------------------ -------------------------
CUSIP No. 451923106 13G Page 11 of 12 Pages
- ------------------ -------------------------
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
Date: February 17, 1998
BOSTON CAPITAL VENTURES III,
LIMITED PARTNERSHIP
By: BD Partners Limited Partnership
its general Partner
By: /s/ A. Dana Callow, Jr.
----------------------------------
A. Dana Callow, Jr.,
General Partner
BD PARTNERS
LIMITED PARTNERSHIP
By: /s/ A. Dana Callow, Jr.
----------------------------------
A. Dana Callow, Jr.,
General Partner
/s/ A. Dana Callow, Jr.
----------------------------
A. Dana Callow, Jr.
/s/ H.J. von der Goltz
-----------------------------
H.J. von der Goltz
/s/ David Kronfeld
-----------------------------
David Kronfeld
<PAGE>
- ------------------ -------------------------
CUSIP No. 451923106 13G Page 12 of 12 Pages
- ------------------ -------------------------
EXHIBIT 1
JOINT FILING AGREEMENT OF
BOSTON CAPITAL VENTURES III, LIMITED
PARTNERSHIP, BD PARTNERS LIMITED PARTNERSHIP,
A. DANA CALLOW, JR., H. J. VON DER
GOLTZ, AND DAVID KRONFELD
Each of the undersigned hereby agrees that the foregoing Schedule 13G with
respect to the securities of ILEX Oncology, Inc. is filed on behalf of each of
the undersigned pursuant to and in accordance with the provisions of Rule
13d-1(f) under the Securities Exchange Act of 1934, as amended.
Dated February 17, 1998
BOSTON CAPITAL VENTURES III,
LIMITED PARTNERSHIP
By: BD Partners Limited Partnership
its General Partner
By: /s/ A. Dana Callow, Jr.
---------------------------------
A. Dana Callow, Jr.,
General Partner
BD PARTNERS
LIMITED PARTNERSHIP
By: /s/ A. Dana Callow, Jr.
------------------------
A. Dana Callow, Jr.,
General Partner
/s/ A. Dana Callow, Jr.
--------------------------
A. Dana Callow, Jr.
/s/ H.J. von der Goltz
----------------------------
H. J. von der Goltz
/s/ David Kronfeld
----------------------------
David Kronfeld
